Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Adolescents | 1 |
| Anxiety | 1 |
| Children | 1 |
| Correlation | 1 |
| Drug Therapy | 1 |
| Outcomes of Treatment | 1 |
| Pharmacology | 1 |
| Rating Scales | 1 |
| Severity (of Disability) | 1 |
| Sleep | 1 |
| Symptoms (Individual… | 1 |
| More ▼ | |
Source
| Journal of the American… | 1 |
Author
| Davies, Mark | 1 |
| Ginsburg, Golda S. | 1 |
| Riddle, Mark A. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkGinsburg, Golda S.; Riddle, Mark A.; Davies, Mark – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To evaluate the prevalence of somatic symptoms (SSs) in children and adolescents with anxiety disorders; the relationship between SSs and anxiety severity, impairment, and child global functioning; and the impact of fluvoxamine (FLV) versus pill placebo (PBO) on reducing SSs. Method: As part of a double-blind, placebo-controlled trial,…
Descriptors: Severity (of Disability), Adolescents, Rating Scales, Anxiety
